Pacira BioSciences (PCRX) Income Statement: Revenue & Earnings

Pacira BioSciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Pacira BioSciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	700.97	674.98	666.82	541.53	429.65	421.03	337.28
Cost of Revenue	252.01	260.93	199.30	195.80	176.75	106.71	86.85
Gross Profit	448.96	414.05	467.53	345.73	252.90	314.31	250.43
Operating Expenses
Research & Development	81.58	76.26	84.80	55.55	59.42	72.12	55.69
Selling, General & Administrative	294.10	269.44	254.52	199.35	193.52	200.78	177.27
Operating Expenses	351.39	326.73	396.60	255.81	201.38	278.60	232.95
Operating Income	97.57	87.32	60.02	89.92	51.52	10.48	17.48
Other Income/Expense
Interest Income	19.69	11.44	4.54	0.90	4.63	0.00	6.50
Interest Expense	-16.57	-20.31	-39.98	-31.75	-25.67	0.00	20.32
Other Income/Expense	-0.37	-0.19	-22.19	-0.07	1.23	4.98	-2.45
Income
Income Before Tax	-63.11	61.70	13.30	56.40	20.09	-10.75	-0.43
Income Tax Expense	36.45	19.75	-2.61	14.42	-125.43	0.27	0.05
Net Income	-99.56	41.96	15.91	41.98	145.52	-11.02	-0.47
Net Income - Continuous Operations	-99.56	41.96	15.91	41.98	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	176.36	162.90	140.38	118.47	71.42	56.10	33.06
EBIT	97.57	87.32	48.88	89.92	51.52	21.08	19.89
Depreciation & Amortization	78.79	75.57	57.29	28.55	19.91	5.70	0.00
Earnings Per Share
Basic EPS	-2.00	1.00	-	1.00	3.00	-	-
Diluted EPS	-2.00	1.00	-	1.00	3.00	-	-
Basic Shares Outstanding	46.25	46.22	45.52	44.26	42.67	41.51	40.91
Diluted Shares Outstanding	46.25	51.98	46.54	45.63	43.68	41.51	40.91